We have been uniting the injectable and combination products community for the past 9 years. As the industry continues to evolve, we strive to ensure fresh content and discussion points to help you overcome your critical device development challenges.
The 2019 program will focus on how to optimize injectable device development timeline, balance between costs and risks, and still ensuring quality and patient-centricity.
Be part of the 9th Injectables Summit – a flagship gathering for drug and device engineers, program leads, and principal scientists to share their technical advancements and engineering obstacles. Across 3 days we will explore how to accelerate pre-filled syringes to autoinjectors, cost-modelling of parenteral devices for vaccines, and opportunities in connectivity to enhance patient experience, as well as supporting your up-and-coming drug pipeline.
Supported by industry leaders from Pfizer, Allergan, Eli Lilly, Sanofi and Novo Nordisk, we are proud to maintain a peer-led format, showcasing latest case studies across 3 days to help you get inspired, provide best tips to avoid common pitfalls and leave with actionable takeaways.
We’re very excited about the return of this summit in September, joined by 120+ senior experts committed to improving their injectable platforms. To be the first to see the final agenda, register now.